FDA Issues Voluntary Recall of Cough Drop Products by Xiamen Kang Zhongyuan Biotechnology Co., Ltd.
A company based in China has issued a voluntary recall of several cough drop products sold in the United States, as reported by the Food and Drug Administration (FDA). The FDA's decision to recommend the recall followed an inspection of the manufacturing facility on August 15, 2025, which raised concerns about product quality. Xiamen Kang Zhongyuan Biotechnology Co., Ltd., located in Xiamen, China, initiated the recall on March 20, 2026. The FDA has classified this recall as Class II, indicating that exposure to the products could lead to temporary or medically reversible adverse health effects.
The cough drop products affected by the recall include various items, although specific details about the reasons for the recall were not disclosed by the FDA. The recall was prompted by observations made during the facility inspection that could impact the quality of the products. Xiamen Kang Zhongyuan Biotechnology Co., Ltd. took the proactive step of recalling the products to ensure consumer safety and product quality standards are met.
The FDA has classified this recall as Class II, indicating that the use of the affected products may result in temporary or medically reversible adverse health consequences. It is essential for consumers who have purchased the recalled cough drop products to discontinue use and follow the guidelines provided by the FDA and the manufacturer. The safety and well-being of consumers are of utmost importance, and this recall serves as a precautionary measure to prevent any potential health risks associated with the products.
In conclusion, the voluntary recall of cough drop products by a China-based company underscores the importance of maintaining high product quality standards and ensuring consumer safety. The FDA's classification of the recall as Class II highlights the potential health risks associated with the use of the affected products. Consumers are advised to heed the recall notice, discontinue use of the products, and follow the guidelines provided to safeguard their health and well-being.